[ad_1]
“At the moment, of the doses received from Moderna, around 78,000 doses, more than 77,000 have already been administered to people who are scheduled for vaccination. I can tell you that we no longer have any doses of Moderna in stock. Next week we will receive the next installment in February and the last one, from the Moderna company, of approximately 79,000 doses, which means that we will not give them for use, but will be kept to ensure the reinforcement. I’ve been talking since February. In March, we will probably receive approximately 230,000 – 240,000 doses in two different tranches, but we do not yet have a confirmed schedule, “said Valeriu Gheorghiţă.
When asked if there were any question marks related to the AstraZeneca vaccine, Gheorghiţă explained that after its administration, there were no side effects that were not mentioned in the package insert.
“We consider that the evolution and the number of vaccinated people is approximately what we expected, considering that we have opened approximately 10,800 daily vaccination places and we have a little more than 9,000 vaccinated every day, and from my point of view yes. not to record adverse reactions to the safety profile that are not mentioned in the summary of product characteristics “, Gheorghiţă also stated.
Gheorghiţă was also asked if the AstraZeneca company’s vaccine is as safe as the other two, replying that “we shouldn’t even raise the issue this way.”
“Definitely, yes. Nor should we pose the question in this way, as it has received a recommendation from the European Medicines Agency. It is also a vaccine that has an effectiveness rate that allows us to use it in the clearest way possible and with the maximum benefits for vaccinated people, given the following aspects: protection is almost 100% against severe forms of the disease, compared to hospitalizations. Basically, the level of protection that vaccination with AstraZeneca is the best possible. Data from studies showing a 67 percent decrease in symptomatic effects because the study protocol allowed weekly testing of everyone in that study and there was a significant decrease in the rate of symptomatic infection. In the vaccines we use each year for seasonal flu, which have an efficacy rate of 40-60 percent, data from the AstraZeneca vaccine currently show an efficacy rate of 76-82 percent, taking into account the timing of the second dose, “stated Gheorghiţă.
Regarding the side effects of COVID-19 vaccines, Gheorghiţă explained that most of them last around 24 hours.
“Through vaccination, we practically train the body’s immune response for the moment when it will finally encounter the virus, to meet that challenge. But the intensity is definitely much easier and we are talking about up to a headache day. , fever, ”added Valeriu Gheorghiţă.
